pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

13,713 catalysts · 3,402 8k filing · 2,401 grant · 2,188 approval · 1,517 device 510k · 1,123 device recall · 1,026 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 22 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-21×clear all
type
  • 8k filing3,402
  • grant2,401
  • approval2,188
  • device 510k1,517
  • device recall1,123
  • device pma1,026
device adverse event
1,000
  • earnings584
  • recall391
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Dec 1, 2025

    50
    ›Dec 1, 2025grant261d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Relative and synergistic contributions of PD1 and LAG3 on CD4+ T conventional...

    CA grant. $75,520. PI: Nicole Mihalik

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoWASHINGTON UNIVERSITY — Investigating the role of brain-engrafted monocyte-derived macrophages in Alz...

    AG grant. $51,038. PI: Siling Du

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $91,297. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoCHIANG MAI UNIVERSITY — Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)

    AI grant. $264,444. PI: Kiat Ruxrungtham

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoFRED HUTCHINSON CANCER CENTER — HIV Vaccines Clinical Trials Network Leadership and Operations Center

    AI grant. $1. PI: Dan H. Barouch

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoFRED HUTCHINSON CANCER CENTER — HIV Vaccines Clinical Trials Network Leadership and Operations Center

    AI grant. $1. PI: Dan H. Barouch

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoFRED HUTCHINSON CANCER CENTER — HIV Vaccines Clinical Trials Network Leadership and Operations Center

    AI grant. $1. PI: Dan H. Barouch

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $90,688. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $288,709. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $1. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $105,412. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoASOCIACION CIVIL IMPACTA SALUD Y EDUCACN — PERU Clinical Trial Unit

    AI grant. $75,000. PI: Alberto La Rosa

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoJOHNS HOPKINS UNIVERSITY — Quantitative CEST MRI for GBM Early Response Prediction and Biopsy GuidanceJohns Hopkins University

    CA grant. $350,599. PI: Shanshan Jiang

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoDUKE UNIVERSITY — Mitigation of gastrointestinal acute radiation syndrome by promoting clusteri...Duke University

    AI grant. $110,922. PI: David Guy Kirsch

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF NEW HAMPSHIRE — Newt iris to lens reprogramming as a model to study eye tissue regeneration i...

    GM grant. $189,459. PI: Konstantinos Sousounis

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Biomarkers of ischemic risk in adults with sickle cell disease

    HL grant. $78,040. PI: Megan Aumann

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Orexinergic neurons, ethanol dependence, and voluntary ethanol consumption

    AA grant. $75,520. PI: Christopher D Walker

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoCLEVELAND CLINIC LERNER COM-CWRU — SMARCA5 Inhibition as a Therapeutic Target for Glioblastoma

    CA grant. $41,876. PI: Molly Guthrie

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoHARVARD MEDICAL SCHOOL — Characterizing a cortical cell-type-specific signal for navigational errors

    NS grant. $44,020. PI: Henry Kyoung

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Clec12A regulation of the intestinal immune response and microbiota compositionUniversity of Utah

    DK grant. $42,418. PI: Morgan Harwood

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoHARVARD UNIVERSITY — Stability of Odor Representations in the Olfactory Tubercle

    DC grant. $46,145. PI: Hannah McCalmon

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF VIRGINIA — XIRP2 in Stereocilia F-Actin RepairUniversity of Virginia

    DC grant. $38,922. PI: Alyssa Luz-Ricca

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoDANA-FARBER CANCER INST — Impact of preanalytical conditions on functional cancer biomarkers

    CA grant. $406,351. PI: Patrick Bhola

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $35,137. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF MIAMI SCHOOL OF MEDICINE — Dose-Dependent and Region-Specific Impacts of siRNA mediated APP Knockdown on...

    AG grant. $45,294. PI: Robyn Jo McCartan

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Low - Field MR Fingerprinting for Myocardial Tissue Characterization in Patie...

    EB grant. $74,632. PI: Calder Sheagren

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Leadership and Operations Center (LOC), AIDS Clinical Trials Group

    AI grant. $193,508. PI: Joseph J Eron

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF WISCONSIN-MADISON — Light adaptation in regionally and functionally distinct retinal circuits

    EY grant. $83,224. PI: Andrew Howard Miller

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — MERIT Extension of Optimization of a remote intervention to improve nutrition...University of California San Francisco

    CA grant. $691,400. PI: Erin Lynn Van Blarigan

    full page →nih reporter ↗
    ›Dec 1, 2025grant261d agoUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR — Gene Regulatory Mechanisms of the Coronary Artery Disease Gene PRDM16 on Smoo...

    HL grant. $145,044. PI: Brian T. Palmisano

    full page →nih reporter ↗
    ›Dec 2, 2025approval260d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

    Sponsor: ELITE LABS INC. Form: TABLET. Route: ORAL

    full page →acetaminophen ER →fda approvals ↗
    ›Dec 2, 2025approval260d agoTEVIMBRA (TISLELIZUMAB-JSGR) — FDA approvalBeOne Medicines Ltd.

    Sponsor: BEIGENE. Form: INJECTION. Route: SOLUTION

    full page →fda approvals ↗
    ›Dec 2, 2025approval260d agoOLANZAPINE — FDA approvalTorrent Pharma Inc

    Sponsor: TORRENT PHARMS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 2, 2025approval260d agoJAYPIRCA (PIRTOBRUTINIB) — FDA approvalEli Lilly and Co

    Sponsor: LOXO ONCOL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Dec 2, 2025approval260d agoPROPOFOL — FDA approvalBika Biotechnology Guanzhou Co Ltd

    Sponsor: NANJING KING FRIEND. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Dec 2, 2025approval260d agoLEVETIRACETAM — FDA approvalLEVETIRACETAM

    Sponsor: KNACK. Form: INJECTABLE. Route: INTRAVENOUS

    full page →LEVETIRACETAM →fda approvals ↗
    ›Dec 2, 2025approval260d agoSITAGLIPTIN AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) — FDA approvalmetformin hydrochloride ER

    Sponsor: SANDOZ. Form: TABLET. Route: ORAL

    full page →metformin hydrochloride ER →fda approvals ↗
    ›Dec 2, 2025device 510k260d agoBecton, Dickinson and Company — 0.9 % Sodium Chloride Injection, USP, BD PosiFlush™ SP Syringe (510k cleared)BECTON DICKINSON & CO

    Product code: NGT. Advisory committee: General Hospital. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 2, 2025device 510k260d agoIntuitive Surgical, Inc. — da Vinci SP Surgical System (SP1098) (510k cleared)INTUITIVE SURGICAL INC

    Product code: NAY. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 2, 2025device 510k260d agoChangzhou New Med Micro-Medtech Co., Ltd. — Disposable Endoscopic Injection Needles (510k cleared)

    Product code: FBK. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 2, 2025device 510k260d agoAura Wellness, LLC — Aura Wave (510k cleared)

    Product code: SGT. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 2, 2025device 510k260d agoMighty Oak Medical — Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX) (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Dec 2, 2025device pma260d agoMedtronic, Inc. — Micra A V2 TPS (MC2AVR1); Micra VR2 TPS (MC2VR01) (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: PNJ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Dec 2, 2025device recall260d agoZimmer, Inc. device recall (Cls II)

    Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815509420 Software Version: N/A Product Description: Affixus 9 mm, Length 420 mm, Right, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 2, 2025device recall260d agoZimmer, Inc. device recall (Cls II)

    Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815509380 Software Version: N/A Product Description: Affixus 9 mm, Length 380 mm, Right, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 2, 2025device recall260d agoZimmer, Inc. device recall (Cls II)

    Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815609320 Software Version: N/A Product Description: Affixus 9 mm, Length 320 mm, Left, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 2, 2025device recall260d agoMicrobiologics Inc device recall (Cls II)FibroBiologics, Inc.

    KWIK-STIK 2-Pack, Campylobacter jejuni subsp. jejuni derived from ATCC 29428, Catalog Number 0325P — Reason: Affected units may fail to recover the target microorganism Campylobacter jejuni subsp. jejuni derived from ATCC 29428. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 2, 2025device recall260d agoZimmer, Inc. device recall (Cls II)

    Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815509340 Software Version: N/A Product Description: Affixus 9 mm, Length 340 mm, Right, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 2, 2025device recall260d agoZimmer, Inc. device recall (Cls II)

    Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815809280 Software Version: N/A Product Description: Affixus 9 mm, Length 280 mm, Left, Priformis Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing

    full page →fda device recalls ↗
    ›Dec 2, 2025device recall260d agoZimmer, Inc. device recall (Cls II)

    Brand Name: Affixus Antegrade Femoral Nailing System Product Name: Affixus Antegrade Femoral Nails Model/Catalog Number: 815609300 Software Version: N/A Product Description: Affixus 9 mm, Length 300 mm, Left, Trochanteric Nail Component: N/A — Reason: Affected implants may have undersized distal diameter along length of the shaft, which could lead to implant fatigue fracture. Potential health risk if implant fatigue fracture occurs include adverse local tissue reaction, pain or ache, non-union or malunion, or tissue damage necessitating surgical intervention. — Status: Ongoing

    full page →fda device recalls ↗
    ← prev
    page 33 of 275
    next →
    $FBLG
    $MDT92.64+2.25%
    $BDX181.08-0.55%
    $ISRG397.11+1.74%
    $ONC369.36+1.89%